Management of delayed cerebral ischemia after subarachnoid hemorrhage

被引:0
作者
Charles L. Francoeur
Stephan A. Mayer
机构
[1] CHU de Québec-Université Laval,Critical Care Division, Department of Anesthesiology and Critical Care
[2] Mount Sinai,Department of Neurology (Neurocritical Care)
[3] Icahn School of Medicine at Mount Sinai,Institute for Critical Care Medicine
来源
Critical Care | / 20卷
关键词
Delayed cerebral ischemia; Subarachnoid hemorrhage; Vasospasm; Multimodality monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
For patients who survive the initial bleeding event of a ruptured brain aneurysm, delayed cerebral ischemia (DCI) is one of the most important causes of mortality and poor neurological outcome. New insights in the last decade have led to an important paradigm shift in the understanding of DCI pathogenesis. Large-vessel cerebral vasospasm has been challenged as the sole causal mechanism; new hypotheses now focus on the early brain injury, microcirculatory dysfunction, impaired autoregulation, and spreading depolarization. Prevention of DCI primarily relies on nimodipine administration and optimization of blood volume and cardiac performance. Neurological monitoring is essential for early DCI detection and intervention. Serial clinical examination combined with intermittent transcranial Doppler ultrasonography and CT angiography (with or without perfusion) is the most commonly used monitoring paradigm, and usually suffices in good grade patients. By contrast, poor grade patients (WFNS grades 4 and 5) require more advanced monitoring because stupor and coma reduce sensitivity to the effects of ischemia. Greater reliance on CT perfusion imaging, continuous electroencephalography, and invasive brain multimodality monitoring are potential strategies to improve situational awareness as it relates to detecting DCI. Pharmacologically-induced hypertension combined with volume is the established first-line therapy for DCI; a good clinical response with reversal of the presenting deficit occurs in 70 % of patients. Medically refractory DCI, defined as failure to respond adequately to these measures, should trigger step-wise escalation of rescue therapy. Level 1 rescue therapy consists of cardiac output optimization, hemoglobin optimization, and endovascular intervention, including angioplasty and intra-arterial vasodilator infusion. In highly refractory cases, level 2 rescue therapies are also considered, none of which have been validated. This review provides an overview of current state-of-the-art care for DCI management.
引用
收藏
相关论文
共 873 条
[61]  
Menon D(2014)HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischem Int J Stroke 9 375-80
[62]  
Shutter L(1990)Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (“Triple-H” therapy) after subarachnoid hemorrhage Neurosurery 27 729-40
[63]  
Vespa P(2010)Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage Neurocrit Care 13 313-20
[64]  
Bruder N(2000)Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial Stroke. 31 383-91
[65]  
Connolly ES(2005)Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage J Neurosurg 103 974-81
[66]  
Citerio G(2015)Positive fluid balance is associated with poor outcomes in subarachnoid hemorrhage J Stroke Cerebrovasc Dis 24 2245-51
[67]  
Gress D(1999)A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care N Engl J Med 340 409-17
[68]  
Hänggi D(2011)Anemia and transfusion after subarachnoid hemorrhage Neurocrit Care 15 342-53
[69]  
Hoh BL(2007)Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage Crit Care Med 35 2383-9
[70]  
Lanzino G(2009)Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage Neurocrit Care 10 157-65